Mast cells, angiogenesis and cancer

Domenico Ribatti, Enrico Crivellato

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Mast cells (MCs) were first described by Paul Ehrlich 1 in his doctoral thesis. MCs have long been implicated in the pathogenesis of allergic reactions and certain protective responses to parasites. As most tumors contain inflammatory cell infiltrates, which often include plentiful MCs, the question as to the possible contribution of MCs to tumor development has progressively been emerging. In this chapter, the specific involvement of MCs in tumor biology and tumor fate will be considered, with particular emphasis on the capacity of these cells to stimulate tumor growth by promoting angiogenesis and lymphangiogenesis. Data from experimental carcinogenesis and from different tumor settings in human pathology will be summarized. Information to be presented will suggest that MCs may serve as a novel therapeutic target for cancer treatment.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
Pages270-288
Number of pages19
Volume716
DOIs
Publication statusPublished - 2011

Publication series

NameAdvances in Experimental Medicine and Biology
Volume716
ISSN (Print)00652598

Fingerprint

Mast Cells
Tumors
Neoplasms
Oncology
Lymphangiogenesis
Pathology
Hypersensitivity
Carcinogenesis
Parasites
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Ribatti, D., & Crivellato, E. (2011). Mast cells, angiogenesis and cancer. In Advances in Experimental Medicine and Biology (Vol. 716, pp. 270-288). (Advances in Experimental Medicine and Biology; Vol. 716). https://doi.org/10.1007/978-1-4419-9533-9_14

Mast cells, angiogenesis and cancer. / Ribatti, Domenico; Crivellato, Enrico.

Advances in Experimental Medicine and Biology. Vol. 716 2011. p. 270-288 (Advances in Experimental Medicine and Biology; Vol. 716).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ribatti, D & Crivellato, E 2011, Mast cells, angiogenesis and cancer. in Advances in Experimental Medicine and Biology. vol. 716, Advances in Experimental Medicine and Biology, vol. 716, pp. 270-288. https://doi.org/10.1007/978-1-4419-9533-9_14
Ribatti D, Crivellato E. Mast cells, angiogenesis and cancer. In Advances in Experimental Medicine and Biology. Vol. 716. 2011. p. 270-288. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4419-9533-9_14
Ribatti, Domenico ; Crivellato, Enrico. / Mast cells, angiogenesis and cancer. Advances in Experimental Medicine and Biology. Vol. 716 2011. pp. 270-288 (Advances in Experimental Medicine and Biology).
@inbook{65f11dcea31c441384e4547ed372b392,
title = "Mast cells, angiogenesis and cancer",
abstract = "Mast cells (MCs) were first described by Paul Ehrlich 1 in his doctoral thesis. MCs have long been implicated in the pathogenesis of allergic reactions and certain protective responses to parasites. As most tumors contain inflammatory cell infiltrates, which often include plentiful MCs, the question as to the possible contribution of MCs to tumor development has progressively been emerging. In this chapter, the specific involvement of MCs in tumor biology and tumor fate will be considered, with particular emphasis on the capacity of these cells to stimulate tumor growth by promoting angiogenesis and lymphangiogenesis. Data from experimental carcinogenesis and from different tumor settings in human pathology will be summarized. Information to be presented will suggest that MCs may serve as a novel therapeutic target for cancer treatment.",
author = "Domenico Ribatti and Enrico Crivellato",
year = "2011",
doi = "10.1007/978-1-4419-9533-9_14",
language = "English",
isbn = "9781441995322",
volume = "716",
series = "Advances in Experimental Medicine and Biology",
pages = "270--288",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Mast cells, angiogenesis and cancer

AU - Ribatti, Domenico

AU - Crivellato, Enrico

PY - 2011

Y1 - 2011

N2 - Mast cells (MCs) were first described by Paul Ehrlich 1 in his doctoral thesis. MCs have long been implicated in the pathogenesis of allergic reactions and certain protective responses to parasites. As most tumors contain inflammatory cell infiltrates, which often include plentiful MCs, the question as to the possible contribution of MCs to tumor development has progressively been emerging. In this chapter, the specific involvement of MCs in tumor biology and tumor fate will be considered, with particular emphasis on the capacity of these cells to stimulate tumor growth by promoting angiogenesis and lymphangiogenesis. Data from experimental carcinogenesis and from different tumor settings in human pathology will be summarized. Information to be presented will suggest that MCs may serve as a novel therapeutic target for cancer treatment.

AB - Mast cells (MCs) were first described by Paul Ehrlich 1 in his doctoral thesis. MCs have long been implicated in the pathogenesis of allergic reactions and certain protective responses to parasites. As most tumors contain inflammatory cell infiltrates, which often include plentiful MCs, the question as to the possible contribution of MCs to tumor development has progressively been emerging. In this chapter, the specific involvement of MCs in tumor biology and tumor fate will be considered, with particular emphasis on the capacity of these cells to stimulate tumor growth by promoting angiogenesis and lymphangiogenesis. Data from experimental carcinogenesis and from different tumor settings in human pathology will be summarized. Information to be presented will suggest that MCs may serve as a novel therapeutic target for cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=79960896329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960896329&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-9533-9_14

DO - 10.1007/978-1-4419-9533-9_14

M3 - Chapter

C2 - 21713661

AN - SCOPUS:79960896329

SN - 9781441995322

VL - 716

T3 - Advances in Experimental Medicine and Biology

SP - 270

EP - 288

BT - Advances in Experimental Medicine and Biology

ER -